To evaluate the pattern of SRXN1 protein expression in PCa, IHC analysis was performed, and we observed increased SRXN1 protein expression (higher intensity immunostaining) in prostate tumors compared to WT tissue (Figure 2(b)). The gene discussed is SRXN1; the disease is prostate neoplasm.